Awareness & Advocacy (Page 5)

ICER is currently reviewing the new class of CGRP inhibitor medications for migraine prevention. At least one of these new treatments is expected to be available by prescription in 2018. Part of the ICER Review of CGRP inhibitor medications includes requests for patient input.